Skalny AV, Rink L, Ajsuvakova OP, Aschner M, Gritsenko VA, Alekseenko SI, et al. Zinc and respiratory tract infections: perspectives for COVID-19. Int J Mol Med. 2020;46(1):17–26.

CAS  PubMed  PubMed Central  Google Scholar 

Turk C, Turk S, Malkan U, Haznedaroglu IC. Three critical clinicobiological phases of the human SARS-associated coronavirus infections. 2020.

Sahebnasagh A, Mojtahedzadeh M, Najmeddin F, Najafi A, Safdari M, Ghaleno HR, et al. A perspective on erythropoietin as a potential adjuvant therapy for acute lung injury/acute respiratory distress syndrome in patients with COVID-19. Arch Med Res. 2020;51:631.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Channappanavar R, Perlman S, editors. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Seminars in immunopathology; 2017: Springer.

Wang Y, Lu X, Li Y, Chen H, Chen T, Su N, et al. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med. 2020;201(11):1430–4.

CAS  PubMed  PubMed Central  Article  Google Scholar 

McGonagle D, O’Donnell JS, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020;2(7):e437–45.

PubMed  PubMed Central  Article  Google Scholar 

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–8.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Iba T, Levy JH, Thachil J, Wada H, Levi M. The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseases. Thromb Res. 2019;179:11–4.

CAS  PubMed  Article  Google Scholar 

Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033–40.

CAS  PubMed  Article  Google Scholar 

Martines RB, Ritter JM, Matkovic E, Gary J, Bollweg BC, Bullock H, et al. Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States. Emerg Infect Dis. 2020;26(9):2005.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Robba C, Battaglini D, Pelosi P, Rocco PR. Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. Expert Rev Respir Med. 2020;14(9):865–8.

CAS  PubMed  Article  Google Scholar 

Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020;12(4):372.

CAS  PubMed Central  Article  Google Scholar 

Hou Y, Zhao J, Martin W, Kallianpur A, Chung MK, Jehi L, et al. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Med. 2020;18(1):1–8.

Article  CAS  Google Scholar 

Iwasaki M, Saito J, Zhao H, Sakamoto A, Hirota K, Ma D. Inflammation triggered by SARS-CoV-2 and ACE2 augment drives multiple organ failure of severe COVID-19: molecular mechanisms and implications. Inflammation. 2020;44:13.

PubMed  Article  CAS  Google Scholar 

Laguna-Goya R, Utrero-Rico A, Talayero P, Lasa-Lazaro M, Ramirez-Fernandez A, Naranjo L, et al. IL-6–based mortality risk model for hospitalized patients with COVID-19. J Allergy Clin Immunol. 2020;146(4):799-807.e9.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, et al. How COVID-19 induces cytokine storm with high mortality. Inflamm Regener. 2020;40(1):37.

CAS  Article  Google Scholar 

Torres Acosta MA, Singer BD. Pathogenesis of COVID-19-induced ARDS: implications for an ageing population. Eur Respir J. 2020;56(3):2002049.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Levi M, Hunt BJ. Thrombosis and coagulopathy in COVID-19: an illustrated review. Res Pract Thromb Haemost. 2020;4(5):744–51.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wang Z, Gao X, Miao H, Ma X, Ding R. Understanding COVID-19-associated coagulopathy: from PIC to SIC or DIC. J Intensive Med. 2021;1(01):35–41.

CAS  Article  Google Scholar 

Marongiu F, Grandone E, Barcellona D. Pulmonary thrombosis in 2019-nCoV pneumonia? J Thromb Haemost. 2020;18:1511.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Gordo MP, Weiland GB, García MG, Choperena GA. Radiologic aspects of COVID-19 pneumonia: outcomes and thoracic complications. Radiología (English Edition). 2021;63(1):74–88.

Article  Google Scholar 

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9.

CAS  PubMed  PubMed Central  Article  Google Scholar 

McGonagle D, Sharif K, O’Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6): 102537.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Belen-Apak FB, Sarıalioğlu F. Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy. J Thromb Thrombolysis. 2020;50:278.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Szegedi I, Orbán-Kálmándi R, Csiba L, Bagoly Z. Stroke as a potential complication of COVID-19-associated coagulopathy: a narrative and systematic review of the literature. J Clin Med. 2020;9(10):3137.

CAS  PubMed Central  Article  Google Scholar 

Bautista-Vargas M, Bonilla-Abadía F, Cañas CA. Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19. J Thromb Thrombolysis. 2020;50:479.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Hottz ED, Azevedo-Quintanilha IG, Palhinha L, Teixeira L, Barreto EA, Pão CRR, et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020;136(11):1330–41.

CAS  PubMed  Article  Google Scholar 

Grobler C, Maphumulo SC, Grobbelaar LM, Bredenkamp JC, Laubscher GJ, Lourens PJ, et al. Covid-19: The rollercoaster of fibrin (ogen), d-dimer, von willebrand factor, p-selectin and their interactions with endothelial cells, platelets and erythrocytes. Int J Mol Sci. 2020;21(14):5168.

CAS  PubMed Central  Article  Google Scholar 

Medcalf RL, Keragala CB, Myles PS. Fibrinolysis and COVID-19: a plasmin paradox. J Thromb Haemost. 2020;18(9):2118–22.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–9.

CAS  PubMed  Article  Google Scholar 

Chen H-R, Chao C-H, Liu C-C, Ho T-S, Tsai H-P, Perng G-C, et al. Macrophage migration inhibitory factor is critical for dengue NS1-induced endothelial glycocalyx degradation and hyperpermeability. PLoS Pathog. 2018;14(4): e1007033.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Morici N, Bottiroli M, Fumagalli R, Marini C, Cattaneo M. Role of von Willebrand factor and ADAMTS-13 in the pathogenesis of thrombi in SARS-CoV-2 infection: time to rethink. Thromb Haemost. 2020;120(9):1339–42.

PubMed  Article  Google Scholar 

Bazzan M, Montaruli B, Sciascia S, Cosseddu D, Norbiato C, Roccatello D. Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients. Intern Emerg Med. 2020;15(5):861–3.

PubMed  PubMed Central  Article  Google Scholar 

Henry BM, Benoit SW, Hoehn J, Lippi G, Favaloro EJ, Benoit JL. Circulating plasminogen concentration at admission in patients with coronavirus disease 2019 (COVID-19). Semin Thromb Hemost. 2020;46(07):859–62.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Khan SS. The central role of plasminogen activator inhibitor-1 in COVID-19: thrombosis and beyond. Am J Respir Cell Mol Biol. 2021.

Lijnen HR. Matrix metalloproteinases and cellular fibrinolytic activity. Biochem Mosc. 2002;67(1):92–8.